Related Experiment Video
Updated: Mar 19, 2026

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin
Published on: March 24, 2023
YAP enters the mTOR pathway to promote tuberous sclerosis complex
1Institut Necker-Enfants Malades; Paris, France; Inserm, U1151; Paris, France; Université Paris Descartes; Sorbonne Paris Cité; Paris, France.
Abstract:
Mutations in tuberous sclerosis complex 1 (TSC1) or TSC2 predispose to angiomyolipomas and lymphangioleiomyomatosis in a mTOR-dependent manner. In these mesenchymal lesions, mTOR suppresses macroautophagy-mediated lysosomal degradation of YAP, which is a transcriptional coactivator of Hippo pathway and is required for the tumorigenesis of TSC. Therapeutic applications for TSC and other diseases with dysregulated mTOR activity can be envisaged.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Microtubules in Signaling
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Microtubule Associated Proteins (MAPs)

